Provided by Tiger Fintech (Singapore) Pte. Ltd.

PTC Therapeutics

49.76
+0.23000.46%
Post-market: 49.760.00000.00%17:44 EDT
Volume:938.30K
Turnover:46.64M
Market Cap:3.92B
PE:-10.53
High:50.41
Open:49.69
Low:49.11
Close:49.53
Loading ...
Apr 17, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 17, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 31, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 29, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 27, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 27, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 24, 2023

Major Issues Report

8-K - Current report
Mar 08, 2023

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 21, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 21, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 06, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 01, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 09, 2023

Major Issues Report

8-K - Current report
Dec 16, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Dec 06, 2022

Major Issues Report

8-K - Current report
Oct 27, 2022

Major Issues Report

8-K - Current report
Oct 27, 2022

Major Issues Report

8-K - Current report
Oct 27, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]